Shantha’s Pentavalent Pediatric Vaccine prequalified by World Health Organization

Shan5(TM)¬†is the first vaccine jointly developed by the Indian company¬†and its parent company Sanofi Pasteur WHO’s decision allows for the purchase of Shan5(TM) by United Nations agencies May 5, 2014 Sanofi Pasteur, the vaccines division of Sanofi, announced today that its pediatric pentavalent vaccine Shan5(TM), developed and manufactured by its affiliate Shantha Biotechnics in Hyderabad, India, has received prequalification status …

Pentavalent Vaccine to Conquer India

The pentavalent vaccine is the vaccine equivalent of buy 1, get 5 free. It prevents against diphtheria, pertussis, tetanus, hepatitis B and haemophilus influenzae type B. A vaccine which kills 5 birds with one stone obviously has numerous advantages including: Less complaints from the kids! Lower shipping/transportation costs Lower packaging costs Fewer staff needed to administer the vaccination Less equipment …